Scopolamine augmentation of a newly initiated escitalopram treatment for major depressive disorder: study protocol for a randomized controlled trial

DOI: 10.1186/s13063-018-3132-3

Keywords: Scopolamine, Major depressive disorder, Efficacy, Randomized controlled trial

Full-Text   Cite this paper   Add to My Lib

Abstract:

The online version of this article (10.1186/s13063-018-3132-3) contains supplementary material, which is available to authorized users

Full-Text